<DOC>
	<DOCNO>NCT01215981</DOCNO>
	<brief_summary>Study Design : This randomize , single center study evaluate immune response seasonal influenza vaccine allogeneic hematopoietic stem cell transplant ( HSCT ) recipient receive one vaccine two vaccine dos one month apart . In addition , cohort healthy adult volunteer recruit control confirm immune response single influenza vaccine .</brief_summary>
	<brief_title>Influenza Vaccine Post Allogeneic Transplant</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patient Population HSCT recipient great 60 day post transplant . Age 6 month old great 60 day post post allogeneic hematopoietic cell transplant Show neutrophil recovery , platelet count &gt; 50,000/mm3 ( may transfuse ) , know disease relapse No history previous allergic reaction influenza vaccine , know egg allergy GuillanBarre Syndrome No flu vaccine previous 4 month , Campath previous 6 month , intravenous immune globulin ( IVIG ) previous 3 month Controls : Age 18 50 year No history previous allergic reaction influenza vaccine , know egg allergy GuillanBarre Syndrome No flu vaccine previous 4 month</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>influenza vaccine</keyword>
</DOC>